Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.

MLA

Osterziel, Karl Josef, et al. “Randomised, Double-Blind, Placebo-Controlled Trial of Human Recombinant Growth Hormone in Patients with Chronic Heart Failure Due to Dilated Cardiomyopathy.” Lancet, vol. 351, no. 9111, Apr. 1998, p. 1233. EBSCOhost, https://doi.org/10.1016/S0140-6736(97)11329-0.

APA

Osterziel, K. J., Strohm, O., Schuler, J., Friedrich, M., Hanlein, D., Willenbrock, R., Anker, S. D., Poole-Wilson, P. A., Ranke, M. B., & Dietz, R. (1998). Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet, 351(9111), 1233. https://doi.org/10.1016/S0140-6736(97)11329-0

Chicago

Osterziel, Karl Josef, Oliver Strohm, Jochen Schuler, Matthias Friedrich, Dankward Hanlein, Roland Willenbrock, Stefan D. Anker, Philip A. Poole-Wilson, Michael B. Ranke, and Rainer Dietz. 1998. “Randomised, Double-Blind, Placebo-Controlled Trial of Human Recombinant Growth Hormone in Patients with Chronic Heart Failure Due to Dilated Cardiomyopathy.” Lancet 351 (9111): 1233. doi:10.1016/S0140-6736(97)11329-0.